Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency Disease

This study has been completed.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Morton Cowan, University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT00295971
First received: February 23, 2006
Last updated: November 8, 2012
Last verified: November 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2011
  Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)